Compare SKLZ & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKLZ | SEER |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.0M | 106.0M |
| IPO Year | N/A | 2020 |
| Metric | SKLZ | SEER |
|---|---|---|
| Price | $5.73 | $1.85 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 53.0K | ★ 162.5K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,256,000.00 | $16,376,999.00 |
| Revenue This Year | $13.33 | $22.37 |
| Revenue Next Year | $12.68 | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.11 |
| 52 Week Low | $3.54 | $1.62 |
| 52 Week High | $9.11 | $2.59 |
| Indicator | SKLZ | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 29.16 |
| Support Level | $5.27 | $1.84 |
| Resistance Level | $5.87 | $2.02 |
| Average True Range (ATR) | 0.28 | 0.08 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 80.99 | 5.26 |
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.